None listed
Conditions
Brief summary
Evaluation of New treatment modality for resistant fungal infection of skin by using minocycline and itraconazole in a case group and itraconazole only in a control group . The study hypothesis is that the concurrent administration of minocycline and itraconazole led to rapid and complete recovery with a low recurrence rate and minimal side effects
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
All pateints with recurrent dermatophytosis
Exclusion criteria
Patients with chronic liver and renal diseases, congested heart failure or any chronic heart diseases, pregnant and lactating women, patients with known allergies to both used drugs, poor compliance patients and children below 18, and patients older than 65 years old,